Back to results
US 8,076,345 B2Granted
2-cyanophenyl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine compounds, compositions and uses thereof
AssigneeEvotec AG
InventorsZhi-Liang Wei, Donogh John Roger O'Mahony, Matthew Duncton, John Kincaid, Michael G. Kelly, Zhan Wang
Life of this patent
Estimating the term…
Abstract
Fused heterocyclic compounds are provided according to formula 1: where R1, R2, R3, and m are as defined herein. Provided compounds and pharmaceutical compositions thereof are useful for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, cognitive disorders, anxiety, depression, and others.
Claims24
A compound according to formula 1:
- wherein
- R1 is aryl or heteroaryl unsubstituted or substituted with one or more R4 groups;
- R2 is H, substituted or unsubstituted C1-C6 alkyl or cycloalkyl;
- each R3 and R4 is independently selected from the group consisting of H, alkyl, acyl, acylamino, alkylamino, alkylthio, alkoxy, alkoxycarbonyl, alkylarylamino, arylalkyloxy, arylalkyloxy, amino, aryl, arylalkyl, —SO3H, —SO3R61b, wherein R61b is a substituted or unsubstituted alkyl or a substituted or unsubstituted aryl, —S(O2)R61, wherein R61 is a substituted or unsubstituted alkyl or a substituted or unsubstituted aryl, —SOR61a, wherein R61a is a substituted or unsubstituted alkyl, a substituted or unsubstituted aryl or a substituted or unsubstituted heteroaryl,
- —SR, wherein R is a substituted or unsubstituted alkyl, a substituted or unsubstituted aryl or a substituted or unsubstituted heteroaryl, azido, carbamoyl, carboxyl, cyano, cycloalkyl, cycloheteroalkyl, dialkylamino, halo, heteroaryloxy, heteroaryl, heteroalkyl, hydroxy, nitro, and SH;
- and m is 1, 2, 3, or 4;
- or a pharmaceutically acceptable salt, tautomer or isotopic variant thereof.
4 more elements
Dependencies are inferred from the claim text.